sysa1801
cspc pharmaceuticals,elevation oncology
['sysa1801', 'ca,022,i', 'ca,022,1', 'gastric']
$elev shot up 67% on this #asco23 abstract on anti-claudin18.2 adc sysa1801, but drifted down a bit since. poster has the same nov 2022 cutoff, with 8/17 prs in gastric cancer; safety ok? 
Once had a blue tick. Journalist at Evaluate Vantage. Interested in: oncology, immunology. Not interested in: what stock you bought today.